Biblio

Export 2957 results:
Author Title Type [ Year(Asc)]
Filters: Filter is   [Clear All Filters]
2022
F. Loreto, Fitzgerald, A., Golemme, M., Gunning, S., Win, Z., Patel, N., Carswell, C., Perry, R., Kennedy, A., Edison, P., and Malhotra, P., “Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1179-1187, 2022.
A. Crestini, Santilli, F., Martellucci, S., Carbone, E., Sorice, M., Piscopo, P., and Mattei, V., “Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 503-518, 2022.
M. Abdelhamid, Zhou, C., Ohno, K., Kuhara, T., Taslima, F., Abdullah, M., Jung, C. - G., and Michikawa, M., “Probiotic Bifidobacterium breve Prevents Memory Impairment Through the Reduction of Both Amyloid-β Production and Microglia Activation in APP Knock-In Mouse.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1555-1571, 2022.
D. J. Jester, Vyhnálek, M., Andel, R., Marková, H., Nikolai, T., Laczó, J., Matuskova, V., Cechova, K., Sheardova, K., and Hort, J., “Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1763-1774, 2022.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A., “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
L. Agüera-Ortiz, Babulal, G. M., Bruneau, M. - A., Creese, B., D'Antonio, F., Fischer, C. E., Gatchel, J. R., Ismail, Z., Kumar, S., McGeown, W. J., Mortby, M. E., Nuñez, N. A., de Oliveira, F. F., Pereiro, A. X., Ravona-Springer, R., Rouse, H. J., Wang, H., and Lanctôt, K. L., “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
Y. Leng, Stone, K. L., and Yaffe, K., “Race Differences in the Association Between Sleep Medication Use and Risk of Dementia.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1133-1139, 2022.
M. E. Fowler, Wright, N. C., Triebel, K., Rocque, G. B., Irvin, R., and Kennedy, R. E., “The Relationship Between Prior Cancer Diagnosis and All-Cause Dementia Progression Among US Adults.”, J Alzheimers Dis, vol. 88, no. 2, pp. 521-535, 2022.
E. Marina Gon Cordero, Cuevas-Budhart, M. Angel, Morán, D. Pérez, Villeda, M. Angel Trej, and Gª-Madrid, M. Gomez- Del-, “Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 87, no. 2, pp. 519-528, 2022.
H. - J. Gong, Tang, X., Chai, Y. - H., Qiao, Y. - S., Xu, H., Patel, I., Zhang, J. - Y., Simó, R., and Zhou, J. - B., “Relationship Between Weight-Change Patterns and Cognitive Function: A Retrospective Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1085-1095, 2022.
M. Ota, Sato, N., Nakaya, M., Shigemoto, Y., Kimura, Y., Chiba, E., Yokoi, Y., Tsukamoto, T., and Matsuda, H., “Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.”, J Alzheimers Dis, vol. 90, no. 1, pp. 295-303, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., “Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
D. - D. Zhang, Ou, Y. - N., Fu, Y., Wang, Z. - B., Huang, L. - Y., Tan, L., and Yu, J. - T., “Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 367-380, 2022.
H. Kim, Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., and Goldberg, T. E., “The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1567-1580, 2022.
R. Piccarducci, Caselli, M. Chiara, Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., and Martini, C., “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., “Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.”, J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
Y. Peng, Zhang, L., Zhou, F., Wang, Y., Zhang, X., Fan, J., Li, S., Li, X., and Li, Y., “Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.”, J Alzheimers Dis, vol. 90, no. 1, pp. 185-198, 2022.
P. Kundu, Zimmerman, B., Quinn, J. F., Kaye, J., Mattek, N., Westaway, S. K., and Raber, J., “Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1471-1481, 2022.
A. Sil, Erfani, A., Lamb, N., Copland, R., Riedel, G., and Platt, B., “Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.”, J Alzheimers Dis, vol. 85, no. 2, pp. 755-778, 2022.
F. Rahmani, Wang, Q., McKay, N. S., Keefe, S., Hantler, N., Hornbeck, R., Wang, Y., Hassenstab, J., Schindler, S., Xiong, C., Morris, J. C., Benzinger, T. L. S., and Raji, C. A., “Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
S. Hannonen, Andberg, S., Kärkkäinen, V., Rusanen, M., Lehtola, J. - M., Saari, T., Korhonen, V., Hokkanen, L., Hallikainen, M., Hänninen, T., Leinonen, V., Kaarniranta, K., Bednarik, R., and Koivisto, A. M., “Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
A. E. Weller, Ferraro, T. N., Doyle, G. A., Reiner, B. C., Crist, R. C., and Berrettini, W. H., “Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1233-1247, 2022.

Pages